We regardthis experimental setup as a characteristic in vitro model of airway disease, because CCL5 production is clinically observed in patients with repeated viral infections, eosinophilic asthma, and persistent Th2‐type inflammation. The gene discussed is CCL5; the disease is viral infectious disease.